Anafranil SR discontinued

Anafranil SR is indicated for the treatment of depressive illness and obsessional or phobic states, and for the adjunctive treatment of cataplexy associated with narcolepsy.
Anafranil SR is indicated for the treatment of depressive illness and obsessional or phobic states, and for the adjunctive treatment of cataplexy associated with narcolepsy.

Anafranil SR (clomipramine) 75mg tablets have been discontinued owing to manufacturing issues. Stock of the tricyclic antidepressant is expected to last until June 2015. Prescribers are advised to select an alternative medication based on the patient’s medical needs and history.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...